Skip to main content

Table 2 Data of muscle biopsy with dystrophin staining, deletion detected by multiplex PCR, reading frame, and eligibility to exon skipping therapy

From: The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine

ID no Dystrophin staining Exons deletions Reading frame Amenability to exon skipping
1 Absence 12, 17, 44 Out of frame N/A
2 N/A 3–17, 44 Out of frame N/A
3 N/A 3–17, 44 Out of frame N/A
4 N/A 8–17 Out of frame N/A
5 N/A 45–52 Out of frame Exon 53 skip-amenable
6 Absence 45–52 Out of frame Exon 53 skip-amenable
7 N/A (HE only) 46–50 Out of frame N/A
8 N/A (HE only) 46–50 Out of frame N/A
9 Partly 46–51 Out of frame Exon 45 skip-amenable
10 Absence 48–50 Out of frame Exon 51 skip-amenable
11 Partly 50–51 In frame N/A
12 N/A (HE only) 50 Out of frame Exon 51 skip-amenable
13 N/A 50 Out of frame Exon 53 skip-amenable
14 Absence 50–52 Out of frame Exon 53 skip-amenable
15 Absence 52 Out of frame Exon 51 skip-amenable